These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22146109)

  • 1. Prediction of human plasma concentration-time profiles of monoclonal antibodies from monkey data by a species-invariant time method.
    Oitate M; Nakayama S; Ito T; Kurihara A; Okudaira N; Izumi T
    Drug Metab Pharmacokinet; 2012; 27(3):354-9. PubMed ID: 22146109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of human pharmacokinetics of therapeutic monoclonal antibodies from simple allometry of monkey data.
    Oitate M; Masubuchi N; Ito T; Yabe Y; Karibe T; Aoki T; Murayama N; Kurihara A; Okudaira N; Izumi T
    Drug Metab Pharmacokinet; 2011; 26(4):423-30. PubMed ID: 21606605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interspecies scaling of therapeutic monoclonal antibodies: initial look.
    Ling J; Zhou H; Jiao Q; Davis HM
    J Clin Pharmacol; 2009 Dec; 49(12):1382-402. PubMed ID: 19837907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned?
    Deng R; Iyer S; Theil FP; Mortensen DL; Fielder PJ; Prabhu S
    MAbs; 2011; 3(1):61-6. PubMed ID: 20962582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative prediction of human pharmacokinetics for monoclonal antibodies: retrospective analysis of monkey as a single species for first-in-human prediction.
    Dong JQ; Salinger DH; Endres CJ; Gibbs JP; Hsu CP; Stouch BJ; Hurh E; Gibbs MA
    Clin Pharmacokinet; 2011 Feb; 50(2):131-42. PubMed ID: 21241072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic investigation of the preclinical pharmacokinetics and interspecies scaling of PF-05231023, a fibroblast growth factor 21-antibody protein conjugate.
    Giragossian C; Vage C; Li J; Pelletier K; Piché-Nicholas N; Rajadhyaksha M; Liras J; Logan A; Calle RA; Weng Y
    Drug Metab Dispos; 2015 Jun; 43(6):803-11. PubMed ID: 25805881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Clinical Pharmacokinetics, Prediction of Human Pharmacokinetics and First-in-Human Dose Selection for CNTO 5825, an Anti-Interleukin-13 Monoclonal Antibody.
    Nnane IP; Xu Z; Zhou H; Davis HM
    Basic Clin Pharmacol Toxicol; 2015 Oct; 117(4):219-25. PubMed ID: 25683750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linear pharmacokinetic parameters for monoclonal antibodies are similar within a species and across different pharmacological targets: A comparison between human, cynomolgus monkey and hFcRn Tg32 transgenic mouse using a population-modeling approach.
    Betts A; Keunecke A; van Steeg TJ; van der Graaf PH; Avery LB; Jones H; Berkhout J
    MAbs; 2018 Jul; 10(5):751-764. PubMed ID: 29634430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Various Approaches to Translate Non-Linear Pharmacokinetics of Monoclonal Antibodies from Cynomolgus Monkey to Human.
    Singh R; Moreno M; Stanimirovic D
    Eur J Drug Metab Pharmacokinet; 2021 Jul; 46(4):555-567. PubMed ID: 34120326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of allometric scaling with plasma concentrations predicted by species-invariant time methods.
    Mahmood I; Yuan R
    Biopharm Drug Dispos; 1999 Apr; 20(3):137-44. PubMed ID: 10211866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Human Pharmacokinetics of Antibody-Drug Conjugates From Nonclinical Data.
    Li C; Zhang C; Deng R; Leipold D; Li D; Latifi B; Gao Y; Zhang C; Li Z; Miles D; Chen SC; Samineni D; Wang B; Agarwal P; Lu D; Prabhu S; Girish S; Kamath AV
    Clin Transl Sci; 2019 Sep; 12(5):534-544. PubMed ID: 31115997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of human clearance of therapeutic proteins: simple allometric scaling method revisited.
    Wang W; Prueksaritanont T
    Biopharm Drug Dispos; 2010 May; 31(4):253-63. PubMed ID: 20437464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translate Pharmacokinetics of PD-1/PD-L1 Monoclonal Antibodies from Cynomolgus Monkey to Human: Comparison of Different Approaches.
    Chen W; Wang L; Ruan Z; Lou H; Jiang B
    J Pharm Sci; 2024 Sep; 113(9):2915-2921. PubMed ID: 38986869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Method for the Human Plasma Concentration-Time Profile of a Monoclonal Antibody from the Half-life of Non-human Primates.
    Nakamura G; Ozeki K; Nagayasu M; Nambu T; Nemoto T; Hosoya KI
    Biol Pharm Bull; 2020; 43(5):823-830. PubMed ID: 32378559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational Approach for Predicting Human Pharmacokinetics of Engineered Therapeutic Monoclonal Antibodies with Increased FcRn-Binding Mutations.
    Haraya K; Tachibana T
    BioDrugs; 2023 Jan; 37(1):99-108. PubMed ID: 36449140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of human oral plasma concentration-time profiles using preclinical data: comparative evaluation of prediction approaches in early pharmaceutical discovery.
    Van den Bergh A; Sinha V; Gilissen R; Straetemans R; Wuyts K; Morrison D; Bijnens L; Mackie C
    Clin Pharmacokinet; 2011 Aug; 50(8):505-17. PubMed ID: 21740074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a Target-Mediated Drug Disposition Model to Predict the Human Pharmacokinetics and Target Occupancy of GC1118, an Anti-epidermal Growth Factor Receptor Antibody.
    Park WS; Han S; Lee J; Hong T; Won J; Lim Y; Lee K; Byun HY; Yim DS
    Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):243-249. PubMed ID: 27637171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single Animal Species-Based Prediction of Human Clearance and First-in-Human Dose of Monoclonal Antibodies: Beyond Monkey.
    Mahmood I
    Antibodies (Basel); 2021 Sep; 10(3):. PubMed ID: 34562983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interspecies scaling of the monoclonal anti-EGF receptor ior EGF/r3 antibody disposition using allometric paradigm: is it really suitable?
    Ducongé J; Fernández-Sánchez E; Alvarez D
    Biopharm Drug Dispos; 2004 May; 25(4):177-86. PubMed ID: 15108220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical pharmacokinetics of MI-219, a novel human double minute 2 (HDM2) inhibitor and prediction of human pharmacokinetics.
    Zou P; Zheng N; Yu Y; Yu S; Sun W; McEachem D; Yang Y; Yu LX; Wang S; Sun D
    J Pharm Pharm Sci; 2012; 15(2):265-80. PubMed ID: 22579006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.